Thu. 9 May 2024, 4:46pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.45 per share which beat the analyst consensus estimate of $0.73 by 98.63 percent. This is a 9.85 percent increase over earnings of $1.32 per share from the same period last year. The company reported quarterly sales of $144.923 million which missed the analyst consensus estimate of $146.853 million by 1.31 percent. This is a 0.11 percent increase over sales of $144.767 million the same period last year.